Ajanta Pharma Ltd. - Research Center
532331 AJANTPHARM Group (A) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Sales |
926.07 |
1,085.29 |
945.18 |
1,014.58 |
848.86 |
Operating profit |
227.15 |
327.18 |
273.65 |
276.90 |
144.53 |
Interest |
1.42 |
2.36 |
2.27 |
0.75 |
1.21 |
Gross profit |
259.41 |
338.55 |
323.54 |
307.61 |
180.07 |
EPS (Rs) |
12.88 |
17.42 |
16.81 |
16.78 |
9.28 |
Quarterly
results in details
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Other income |
33.68 |
13.73 |
52.16 |
31.46 |
36.75 |
Stock adjustment |
-59.42 |
31.01 |
-28.16 |
34.40 |
-6.03 |
Raw material |
259.03 |
239.04 |
223.55 |
217.81 |
231.89 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
215.97 |
216.41 |
205.48 |
196.30 |
207.06 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
283.34 |
271.65 |
270.66 |
289.17 |
271.41 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
33.47 |
33.41 |
33.04 |
32.24 |
32.11 |
Taxation |
63.25 |
84.99 |
78.14 |
63.33 |
30.75 |
Net profit / loss |
162.69 |
220.15 |
212.36 |
212.04 |
117.21 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
25.27 |
25.27 |
25.27 |
25.27 |
25.27 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
24.53 |
30.15 |
28.95 |
27.29 |
17.03 |
GPM (%) |
27.03 |
30.80 |
32.44 |
29.41 |
20.33 |
NPM (%) |
16.95 |
20.03 |
21.29 |
20.27 |
13.23 |